期刊文献+

检测中枢性性早熟女童血清维生素D水平的临床意义 被引量:11

原文传递
导出
摘要 目的:评价检测中枢性性早熟(CPP)女童血清中维生素D的临床意义。方法:收集2010年3月~2013年5月在博爱医院门诊就诊的82例CPP女童及82例健康女童,记录一般情况资料;化学发光法检测血清游离甲状腺素(FT4)、促甲状腺素(TSH)、泌乳素(PRL)、黄体生成素(LH)、卵泡刺激素(FSH)、雌二醇(E2)及25-羟基维生素D(25-OHD)水平。结果:CPP女童血清中维生素D含量明显低于对照组女童;血清25-OHD水平与发病年龄、身高标准差分数(HSDS)、体重标准差分数(WSDS)、BMI SDS、骨龄、骨龄与年龄差、卵巢体积无关;但是与乳腺发育年龄密切相关;维生素D缺乏组CPP女童乳腺发育Tanner期Ⅲ~Ⅳ期所占比例明显高于维生素D正常组CPP女童;维生素D缺乏组CPP女童FT4、TSH、PRL、LH及FSH与维生素D正常CPP女童体内水平无差异,而E2的水平明显高于对照组;维生素D缺乏组CPP女童经GnRHa治疗后,乳房发育消退比例低于维生素D正常组,而生长速率及骨龄减速与对照组比较,差异无统计学意义(P〉0.05)。结论:维生素D缺乏与CPP女童乳腺发育年龄及Tanner期密切相关,可能与E2的升高相关,并影响GnRHa治疗对乳房发育消退的疗效。
出处 《中国妇幼保健》 CAS 2015年第18期2997-2998,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献8

  • 1Yang B,Sun H,Wan Y,et al.Associations between testosterone,bone mineral density,vitamin D and semen quality in fertile and infertile Chinese men[J].Int J Androl,2012,35(6):783-792.
  • 2Knight JA,Wong J,Blackmore KM,et al.Vitamin D association with estradiol and progesterone in young women[J].Cancer Causes Control,2010,21(3):479-483.
  • 3Lee HS,Kim YJ,Shim YS,et al.Associations between serum vitamin D levels and precocious puberty in girls[J].Ann Pediatr Endocrinol Metab,2014,19(2):91-95.
  • 4Sorensen K,Mouritsen A,Aksglaede L,et al.Recent secular trends in pubertal timing:implications for evaluation and diagnosis of precocious puberty[J].Horm Res Paediatr,2012,77(3):137-145.
  • 5Ahmed ML,Ong KK,Dunger DB.Childhood obesity and the timing of puberty[J].Trends Endocrinol Metab,2009,20(5):237-242.
  • 6Abrams SA,Coss-Bu JA,Tiosano D.Vitamin D:effects on childhood health and disease[J].Nat Rev Endocrinol,2013,9(3):162-170.
  • 7Bertelloni S,Baroncelli GI.Current pharmacotherapy of central precocious puberty by GnRH analogs:certainties and uncertainties[J].Expert Opin Pharmacother,2013,14(12):1627-1639.
  • 8蔡锡顶,朱蓓,李珍,白敏,沈永年.LHRH激发试验对性早熟女童GnRHa治疗的评估[J].临床儿科杂志,2013,31(12):1121-1124. 被引量:18

二级参考文献9

  • 1黄捷婷,高树彬.国内儿童性早熟研究16年主题文献分析[J].临床儿科杂志,2006,24(12):1016-1017. 被引量:12
  • 2杜敏联.中枢性(真性)性早熟诊治指南[J].中华儿科杂志,2007,45(6):426-427. 被引量:286
  • 3Carel JC. Consensus statement on the use of gonadotropinreleasing hormone analogs in children [J]. Pediatrics, 2009, 123(4): 752-762.
  • 4Brito VN, Latronico AC, Arnhold IJ, et al. A single luteinizing hormone determination 2 hours after depot leuproJide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls [J]. J CJin Endocrinol Metab, 2004, 89(9): 4338-4342.
  • 5Antoniazzi F, Cisternino M, Nizzoli G, et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments [J]. ActaPaediatr, 1994, 83(10): 1052-1056.
  • 6Witchel SF, Baens-Bailon RG, Lee PA. Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy [J]. J Clin Endocrinol Metab, 1996, 81(4): 1353-1356.
  • 7Kunz GJ, Sherman TI, Klein KO. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are preinjection LH levels useful in moniting treatment [J]. J Pediatr Endocrinol Metab, 2007, 20(11) : 1189-1198.
  • 8Acharya SV, Gopal RA, George 1. Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty [J]. Pituitary, 2009, 12(4): 335-338.
  • 9赵金玲,徐庄剑,马亚萍,王勍,张婷婷,卢隽滢.曲普瑞林激发试验对女童曲普瑞林疗效的评估[J].实用儿科临床杂志,2012,27(20):1579-1581. 被引量:9

共引文献17

同被引文献65

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部